Par Drugs and Chemicals has been issued the certificate of WHO-GMP to ensure compliance according to recommendation and guidelines and after detailed due diligence by CDSCO and FDCA.

The company has informed that it underwent for an audit on January 23, 2023 and January 24, 2023 at manufacturing Blocks for APl's located at 333/1, GIDC Industrial Estate, Phase-II, Chitra, Bhavnagar, Gujarat.

The Audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3, jointly by officers of Central Drugs Standard Control Organization (CDSCO) and Food and Drugs Control Administration (FDCA).

The visit fell under the ordinary course of business of the company and was not involving any Unpublished Price sensitive Information during the visit. On the basis of an inspection carried out by them, they have found some minor recommendations which were compiled in time.